251 related articles for article (PubMed ID: 33185110)
1. Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.
Takahara S; Ferdaoussi M; Srnic N; Maayah ZH; Soni S; Migglautsch AK; Breinbauer R; Kershaw EE; Dyck JRB
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H432-H446. PubMed ID: 33185110
[TBL] [Abstract][Full Text] [Related]
2. Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase.
Parajuli N; Takahara S; Matsumura N; Kim TT; Ferdaoussi M; Migglautsch AK; Zechner R; Breinbauer R; Kershaw EE; Dyck JRB
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H879-H884. PubMed ID: 29932770
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage.
Thiele A; Luettges K; Ritter D; Beyhoff N; Smeir E; Grune J; Steinhoff JS; Schupp M; Klopfleisch R; Rothe M; Wilck N; Bartolomaeus H; Migglautsch AK; Breinbauer R; Kershaw EE; Grabner GF; Zechner R; Kintscher U; Foryst-Ludwig A
Cardiovasc Res; 2022 Aug; 118(11):2488-2505. PubMed ID: 34061169
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
Salatzki J; Foryst-Ludwig A; Bentele K; Blumrich A; Smeir E; Ban Z; Brix S; Grune J; Beyhoff N; Klopfleisch R; Dunst S; Surma MA; Klose C; Rothe M; Heinzel FR; Krannich A; Kershaw EE; Beule D; Schulze PC; Marx N; Kintscher U
PLoS Genet; 2018 Jan; 14(1):e1007171. PubMed ID: 29320510
[TBL] [Abstract][Full Text] [Related]
5. New Atglistatin closely related analogues: Synthesis and structure-activity relationship towards adipose triglyceride lipase inhibition.
Roy PP; D'Souza K; Cuperlovic-Culf M; Kienesberger PC; Touaibia M
Eur J Med Chem; 2016 Aug; 118():290-8. PubMed ID: 27155760
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors.
Jin J; Huang S; Wang L; Leng Y; Lu W
Chem Biol Drug Des; 2017 Dec; 90(6):1122-1133. PubMed ID: 28548386
[TBL] [Abstract][Full Text] [Related]
7. Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction.
Bottermann K; Granade ME; Oenarto V; Fischer JW; Harris TE
J Cardiovasc Pharmacol Ther; 2021 May; 26(3):289-297. PubMed ID: 33150796
[TBL] [Abstract][Full Text] [Related]
8. A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice.
Attané C; Peyot ML; Lussier R; Poursharifi P; Zhao S; Zhang D; Morin J; Pineda M; Wang S; Dumortier O; Ruderman NB; Mitchell GA; Simons B; Madiraju SR; Joly E; Prentki M
Diabetologia; 2016 Dec; 59(12):2654-2663. PubMed ID: 27677764
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol regulates lipolysis via adipose triglyceride lipase.
Lasa A; Schweiger M; Kotzbeck P; Churruca I; Simón E; Zechner R; Portillo MP
J Nutr Biochem; 2012 Apr; 23(4):379-84. PubMed ID: 21543206
[TBL] [Abstract][Full Text] [Related]
10. Reduced ATGL-mediated lipolysis attenuates β-adrenergic-induced AMPK signaling, but not the induction of PKA-targeted genes, in adipocytes and adipose tissue.
MacPherson RE; Dragos SM; Ramos S; Sutton C; Frendo-Cumbo S; Castellani L; Watt MJ; Perry CG; Mutch DM; Wright DC
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C269-76. PubMed ID: 27357546
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL).
Mayer N; Schweiger M; Fuchs E; Migglautsch AK; Doler C; Grabner GF; Romauch M; Melcher MC; Zechner R; Zimmermann R; Breinbauer R
Bioorg Med Chem; 2020 Aug; 28(16):115610. PubMed ID: 32690265
[TBL] [Abstract][Full Text] [Related]
12. Adipose Triglyceride Lipase-Mediated Adipocyte Lipolysis Exacerbates Acute Pancreatitis Severity in Mouse Models and Patients.
Xie X; Liu Y; Yang Q; Ma X; Lu Y; Hu Y; Zhang G; Ke L; Tong Z; Liu Y; Xue J; Lu G; Li W
Am J Pathol; 2024 May; ():. PubMed ID: 38705384
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice.
Schweiger M; Romauch M; Schreiber R; Grabner GF; Hütter S; Kotzbeck P; Benedikt P; Eichmann TO; Yamada S; Knittelfelder O; Diwoky C; Doler C; Mayer N; De Cecco W; Breinbauer R; Zimmermann R; Zechner R
Nat Commun; 2017 Mar; 8():14859. PubMed ID: 28327588
[TBL] [Abstract][Full Text] [Related]
14. Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue.
Mottillo EP; Shen XJ; Granneman JG
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1188-97. PubMed ID: 17711991
[TBL] [Abstract][Full Text] [Related]
15. The reduction of lipid-sourced energy production caused by ATGL inhibition cannot be compensated by activation of HSL, autophagy, and utilization of other nutrients in fish.
Han SL; Liu Y; Limbu SM; Chen LQ; Zhang ML; Du ZY
Fish Physiol Biochem; 2021 Feb; 47(1):173-188. PubMed ID: 33245450
[TBL] [Abstract][Full Text] [Related]
16. Development of small-molecule inhibitors targeting adipose triglyceride lipase.
Mayer N; Schweiger M; Romauch M; Grabner GF; Eichmann TO; Fuchs E; Ivkovic J; Heier C; Mrak I; Lass A; Höfler G; Fledelius C; Zechner R; Zimmermann R; Breinbauer R
Nat Chem Biol; 2013 Dec; 9(12):785-7. PubMed ID: 24096302
[TBL] [Abstract][Full Text] [Related]
17. Cardiac oxidative stress in a mouse model of neutral lipid storage disease.
Schrammel A; Mussbacher M; Winkler S; Haemmerle G; Stessel H; Wölkart G; Zechner R; Mayer B
Biochim Biophys Acta; 2013 Nov; 1831(11):1600-8. PubMed ID: 23867907
[TBL] [Abstract][Full Text] [Related]
18. Lipolysis and thermogenesis in adipose tissues as new potential mechanisms for metabolic benefits of dietary fiber.
Han SF; Jiao J; Zhang W; Xu JY; Zhang W; Fu CL; Qin LQ
Nutrition; 2017 Jan; 33():118-124. PubMed ID: 27461561
[TBL] [Abstract][Full Text] [Related]
19. TFE3 controls lipid metabolism in adipose tissue of male mice by suppressing lipolysis and thermogenesis.
Fujimoto Y; Nakagawa Y; Satoh A; Okuda K; Shingyouchi A; Naka A; Matsuzaka T; Iwasaki H; Kobayashi K; Yahagi N; Shimada M; Yatoh S; Suzuki H; Yogosawa S; Izumi T; Sone H; Urayama O; Yamada N; Shimano H
Endocrinology; 2013 Oct; 154(10):3577-88. PubMed ID: 23885019
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic tone dictates the impact of lipolysis on FABP4 secretion.
Prentice KJ; Lee A; Cedillo P; Inouye KE; Ertunc ME; Riveros JK; Lee GY; Hotamisligil GS
J Lipid Res; 2023 Jun; 64(6):100386. PubMed ID: 37172691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
